| Financial Year |
March 31 2023 |
| Monetary Funds |
626,622,973.09 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
5,300,000.00 |
| Accounts Receivable |
216,959,314.55 |
| Advances to Suppliers |
6,939,333.12 |
| Other Receivables |
8,441,359.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
440,903,396.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
83,991.59 |
| Total Current Assets |
1,398,380,216.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
83,621,672.95 |
| Investment Properties |
14,979,247.20 |
| Fixed Assetes |
284,497,018.28 |
| Under-construction Projects |
70,292,645.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
61,029,209.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
326,035.10 |
| Deferred Income Tax Assets |
7,866,894.38 |
| Other Non-Current Assets |
16,177,057.62 |
| Sub-Total of Non-Current Assets |
540,548,265.54 |
| Total Assets |
1,938,928,482.26 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
32,250,000.00 |
| Accounts Payable |
183,630,918.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,462,808.35 |
| Taxes Payable |
16,975,230.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
368,377.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
334,279.43 |
| Other Current Liabilities |
11,179,516.99 |
| Sub-Total of Current Liabilities |
338,197,415.62 |
| Long-term Loans |
-- |
| Bonds Payable |
252,573,350.39 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,601,346.05 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
261,259,477.24 |
| Total Liabilities |
599,456,892.86 |
| Paid-In Capital(Or Share Stock) |
100,000,000.00 |
| Capital Surplus |
386,179,281.71 |
| Surplus Reserve |
49,934,272.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
744,166,295.76 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,339,471,589.40 |
| Owner's Equity（Stockholder's Equity） |
1,339,471,589.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,938,928,482.26 |
